There are 2789 resources available
479P - Difference gene mutations among CRC patients with MSS and MSI-H types in China
Presenter: Jianjun Yang
Session: ePoster Display
480P - Gene expression of NANOG and NANOGP8 in colorectal cancer
Presenter: Hiroyuki Arai
Session: ePoster Display
481P - Evaluation of serum mid-infrared spectroscopy as new prognostic marker for bevacizumab-based chemotherapy in first-line treatment of metastatic colorectal cancer
Presenter: Romain Chautard
Session: ePoster Display
483P - The correlation analysis between MUC16 mutation and immunotherapy predictive biomarkers in colon adenocarcinoma
Presenter: Gong Chen
Session: ePoster Display
484P - CD300c blockade promotes anti-cancer immunity and synergizes with immune checkpoint inhibitor in colon cancer
Presenter: HyeRim Shin
Session: ePoster Display
485P - A phase Ib study of cetuximab combined with fruquintinib in the previously treated RAS/BRAF wild-type metastatic colorectal cancer: The preliminary result of CEFRU study
Presenter: YONG LI
Session: ePoster Display
486P - Bioavailability and activity of oncolytic virus TG6002 after intravenous administration in patients with advanced gastrointestinal carcinomas
Presenter: Philippe A. Cassier
Session: ePoster Display
487P - Targeting PDL-1 in colon cancer using nuclear receptor 4A1 (NR41) antagonist
Presenter: Maen Abdelrahim
Session: ePoster Display
489P - MEN1611 in combination with cetuximab: Targeting PIK3CA mutations in RAS-wild-type patient-derived colorectal cancer xenografts
Presenter: Stefania Capano
Session: ePoster Display
490P - New horizons in metastatic colorectal cancer: Role of CD44 expression
Presenter: Pina Ziranu
Session: ePoster Display